Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03247309
Title TCR-engineered T Cells in Solid Tumors With Emphasis on NSCLC and HNSCC (ACTengine) (ACTengine)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immatics US, Inc.
Indications

oral squamous cell carcinoma

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

pharynx squamous cell carcinoma

lung non-small cell carcinoma

Therapies

Aldesleukin + IMA201

Cyclophosphamide + Fludarabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.